Edesa Biotech Inc

EDSA

Company Profile

  • Business description

    Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

  • Contact

    100 Spy Court
    MarkhamONL3R 5H6
    CAN

    T: +1 289 800-9600

    E: [email protected]

    https://www.edesabiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 September 2025

    Employees

    16

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,741.4016.50-0.19%
CAC 407,553.45102.67-1.34%
DAX 4023,057.38260.43-1.12%
Dow JONES (US)42,171.6644.14-0.10%
FTSE 1008,791.8051.67-0.58%
HKSE23,237.74472.95-1.99%
NASDAQ19,546.2725.180.13%
Nikkei 22538,488.34396.81-1.02%
NZX 50 Index12,569.0558.27-0.46%
S&P 5005,980.871.85-0.03%
S&P/ASX 2008,523.707.50-0.09%
SSE Composite Index3,362.1126.70-0.79%

Market Movers